Search results
Results from the WOW.Com Content Network
The FDA granted the approval of Jatenzo to Clarus Therapeutics. [22] [51] In March 2022, testosterone undecanoate (Tlando) was approved for medical use in the United States. [5] In July 2022, Kyzatrex, an oral testosterone undecanoate capsule, was approved for medical use in the United States.
Per the U.S. Food and Drug Administration (FDA), sertraline is approved to be taken at 25 to 200 milligrams per day. Like other SSRIs, the dosage may change depending on how you feel and what your ...
This is a list of investigational antidepressants, or drugs that are currently under development for clinical use in the treatment of depression but are not yet approved. Specific indications include major depressive disorder, treatment-resistant depression, dysthymia, bipolar depression, and postpartum depression, among others.
Paroxetine was the first drug to be approved for social anxiety disorder and it is considered effective for this disorder; sertraline and fluvoxamine were later approved for it as well. Escitalopram and citalopram are used off-label with acceptable efficacy, while fluoxetine is not considered to be effective for this disorder. [ 22 ]
This is the first pill targeted at depression that occurs shortly after childbirth. Newly approved medication for postpartum depression has ties to Triangle researchers Skip to main content
For premium support please call: 800-290-4726 more ways to reach us
This change appears to remove the antihistaminic properties of the drug. By removing the (R)-enantiomer, the lowest dose of escitalopram becomes more efficacious and faster onset than comparable dose of citalopram, where escitalopram has twice the activity of citalopram and is at least 27 times more potent than the (R)-enantiomer. [6]
Aug. 19—A new drug treating postpartum depression was approved earlier this month by the Food and Drug Administration — possibly filling a gap in care, depending on the drug's accessibility to ...